Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

women who did not nurse during vaccine administration were 540.1 (95% CI: 523.5, 557.2) for anti-HPV 6, 746.3 (95% CI: 720.4, 773.3) for anti-HPV 11, 2290.8 (95% CI: 2180.7, 2406.3) for anti-HPV 16, and 456.0 (95% CI: 438.4, 474.3) for anti-HPV 18. Overall, 17 and 9 infants of subjects who received GARDASIL or placebo, respectively (representing 3.4% and 1.8% of the total number of subjects who were breast-feeding during the period in which they received GARDASIL or placebo, respectively), experienced a serious adverse experience. None was judged by the investigator to be vaccine related. In clinical studies, a higher number of breast-feeding infants (n = 6) whose mothers received GARDASIL had acute respiratory illnesses within 30 days post-vaccination of the mother as compared to infants (n = 2) whose mothers received placebo. In these studies, the rates of other adverse experiences in the mother and the nursing infant were comparable between vaccination groups. Pediatric Use The safety and efficacy of GARDASIL have not been evaluated in children younger than 9 years. Geriatric Use The safety and efficacy of GARDASIL have not been evaluated in adults above the age of 26 years. ADVERSE REACTIONS In 5 clinical trials (4 placebo-controlled), subjects were administered GARDASIL or placebo on the day of enrollment, and approximately 2 and 6 months thereafter. Few subjects (0.1%) discontinued due to adverse experiences. In all except 1 of the clinical trials, safety was evaluated using vaccination report card (VRC)-aided surveillance for 14 days after each injection of GARDASIL or placebo. The subjects who were monitored using VRC-aided surveillance included 5088 girls and women 9 through 26 years of age at enrollment who received GARDASIL and 3790 girls and women who received placebo. Common Adverse Experiences Vaccine-related Common Adverse Experiences The vaccine-related adverse experiences that wer
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:3/1/2015)... 1, 2015  Patients suffering from chronic plantar ... debilitating foot ailment, according to research presented at ... Annual Scientific Meeting . Researchers utilized ultrasound imaging ... remove diseased fasciitis tissue. Permanently removing damaged, pain-generating ... in its place, restoring normal function. ...
(Date:2/27/2015)... CHAPEL HILL, N.C. , Feb. 27, 2015 /PRNewswire/ ... evolved over the past decade but one thing hasn,t ... for MSLs to build relationships with Key Opinion Leaders. ... are recognized as the most valuable type of interaction, ... external limits on their KOL interactions. This is just ...
(Date:2/27/2015)... MARLTON, N.J. , Feb. 27, 2015  Acsis ... collaboration and serialization solutions, announced today that John ... as a Supply & Demand Chain Executive ... chain executives who are leading initiatives to help prepare ... challenges of today,s business climate. This year,s list of ...
Breaking Medicine Technology:Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2
(Date:3/2/2015)... March 02, 2015 Secura Consultants ... relationship with First Protective Insurance Group of Birmingham, ... allow First Protective affiliated advisors to access the ... that Secura Consultants delivers. , Secura ... leader in the design and implementation of insured ...
(Date:3/1/2015)... Michigan (PRWEB) March 01, 2015 Women’s ... to treat Overactive Bladder (OAB) symptoms, such as a strong ... when another type of medication (anticholinergic) does not work well ... treatment option that takes another approach to targeting the source ... works on the nerves and bladder muscle, blocking the signals ...
(Date:3/1/2015)... IL (PRWEB) March 01, 2015 Ticket Down ... Dead in Chicago at Soldier Field. Deadheads have ... announced in January. , Grateful Dead was formed 50 years ... they were together as one until the untimely death of ... for combining different genres including blues, reggae, rock, bluegrass, folk, ...
(Date:3/1/2015)... California (PRWEB) March 01, 2015 Theme ... a new transition pack for Final Cut ... add accordion style transitions to any FCPX editors project.” ... given our users the tools needed to easily drag ... , The user gets many different controls over the ...
(Date:2/28/2015)... OR (PRWEB) February 28, 2015 In ... Duncan Fletcher of Game Change Athlete ... Shannon Leinert about the benefits of athlete development and ... some of the unique challenges that athletes face and ... and future success. , Fletcher became involved in athlete ...
Breaking Medicine News(10 mins):Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3
... HealthDay Reporter , WEDNESDAY, Feb. 29 (HealthDay News) ... ruxolitinib can help people with the rare bone marrow disorder ... States under the brand name Jakafi, won,t cure myelofibrosis, it ... improve survival according to the studies. "This is ...
... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Feb. 29 ... much use in helping pregnant women quit smoking, a new ... Tobacco Control Studies at the University of Nottingham in England, ... weeks pregnant to one of two groups. Members of one ...
... not appear to be a factor in poor sleep, a new ... quality seems to improve over a lifetime, with the fewest complaints ... face of popular belief," said Michael Grandner, PhD, lead author of ... about sleep in older people men and women." The ...
... Orange, NJ -- Jordan Grafman, PhD, director of Traumatic Brain ... The 2nd Annual Traumatic Brain Injury Conference on March 6, ... long-term cognitive and social consequences of traumatic brain injury. A ... the influence of the location of brain injury and genetic ...
... HOUSTON - A drug that relieves the severe symptoms of ... survival of patients with the disease, according to a phase ... New England Journal of Medicine . "The Phase ... for many patients with myelofibrosis and now this phase III ...
... The Cognitive Neuroscience Society (CNS) invites members of the press ... in Chicago at the Palmer House Hotel. See the latest ... connections between sleep and memory, the neurological processes that govern ... in our lives. Highlights will include: , ...
Cached Medicine News:Health News:New Drug May Help Fight Rare Bone Marrow Disorder 2Health News:New Drug May Help Fight Rare Bone Marrow Disorder 3Health News:Nicotine Patches May Not Help During Pregnancy 2Health News:Nicotine Patches May Not Help During Pregnancy 3Health News:Study: Sleep gets better with age, not worse 2Health News:Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC 2Health News:Drug improves survival and quality of life for people with myelofibrosis 2Health News:Drug improves survival and quality of life for people with myelofibrosis 3
... The Modular Shoulder System* ... surgeons with a comprehensive range ... of individual patient needs. With ... Smith + Nephew offers a ...
... The Bio-Modular, for ... shoulder replacement. Modularity in ... range of sizing and ... with one of the ...
... The Bigliani/Flatow shoulder allows for the ... cases of shoulder replacement surgery. Backed ... and decades of experience, the Bigliani/Flatow ... the natural shoulder's mobility, balance, and ...
Comprehensive, unified system for total or hemi shoulder arthroplasty....
Medicine Products: